Industry Strength Score
39/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
CLEARMIND MEDICINE INC (CMND) Stock Price & Overview
NASDAQ:CMND • CA1850535016
Current stock price
0.696 USD
-0.04 (-5.61%)
At close:
0.696 USD
0 (0%)
After Hours:
The current stock price of CMND is 0.696 USD. Today CMND is down by -5.61%. In the past month the price decreased by -33.08%. In the past year, price decreased by -98.28%.
CMND Key Statistics
52-Week Range0.5855 - 52.4
Current CMND stock price positioned within its 52-week range.
1-Month Range0.5855 - 1.52
Current CMND stock price positioned within its 1-month range.
- Market Cap
- 1.044M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -53.93
- Dividend Yield
- N/A
CMND Stock Performance
Today
-5.61%
1 Week
-18.50%
1 Month
-33.08%
3 Months
-67.93%
Longer-term
6 Months -97.81%
1 Year -98.28%
2 Years -98.54%
3 Years -99.90%
5 Years N/A
10 Years N/A
CMND Stock Chart
CMND Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CMND. When comparing the yearly performance of all stocks, CMND is a bad performer in the overall market: 99.11% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
CMND Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CMND. The financial health of CMND is average, but there are quite some concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CMND Earnings
Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ1 / 2026
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
CMND Forecast & Estimates
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
CMND Financial Highlights
Over the last trailing twelve months CMND reported a non-GAAP Earnings per Share(EPS) of -53.93. The EPS decreased by -2.12% compared to the year before.
Income Statements
Revenue(TTM)N/A
Net Income(TTM)-6.64M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -167.27% | ||
| ROE | -623.06% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%-243.86%
Sales Q2Q%N/A
EPS 1Y (TTM)-2.12%
Revenue 1Y (TTM)N/A
CMND Ownership
Ownership
Inst Owners0.44%
Shares1.50M
Float1.43M
Ins Owners0.92%
Short Float %32.44%
Short Ratio0.08
CMND Industry Overview
CMND operates in the Pharmaceuticals sub-industry within the Health Care sector. This group contains 29 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
48/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
65%
Outperformed 65% of sub-industries
3 Month Rank
67%
Outperformed 67% of sub-industries
6 Month Rank
28%
Outperformed 28% of sub-industries
Industry Fundamentals & Breadth
- Members
- 29
- New Highs
- 3.5%
- New Lows
- 13.8%
- Average ROE
- 17.4%
- Average Profit Margin
- 10.2%
- Average Operating Margin
- 19%
- Average P/E
- 5.4
- Average Fwd P/E
- 17.8
- Average Debt/Equity
- 0.5
CMND Competitors/Peers
The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 24.34 | 825.773B | ||
| JNJ | JOHNSON & JOHNSON | 17.92 | 548.657B | ||
| MRK | MERCK & CO. INC. | 21.79 | 271.761B | ||
| PFE | PFIZER INC | 8.79 | 150.628B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.1 | 118.952B | ||
| ZTS | ZOETIS INC | 16.09 | 49.054B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.58 | 28.582B | ||
| VTRS | VIATRIS INC | 6 | 17.257B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 20.72 | 11.061B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.463B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.11B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.955B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.86 | 4.959B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CMND
Company Profile
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Company Info
IPO: 2021-08-10
CLEARMIND MEDICINE INC
101-1220 West 6Th Avenue
Vancouver BRITISH COLUMBIA CA
Employees: 0
Phone: 16042601566
CLEARMIND MEDICINE INC / CMND FAQ
What does CMND do?
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
What is the current price of CMND stock?
The current stock price of CMND is 0.696 USD. The price decreased by -5.61% in the last trading session.
Does CMND stock pay dividends?
CMND does not pay a dividend.
How is the ChartMill rating for CLEARMIND MEDICINE INC?
CMND has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is CMND stock listed?
CMND stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of CLEARMIND MEDICINE INC (CMND)?
CLEARMIND MEDICINE INC (CMND) does not have a PE ratio as the earnings reported over the last twelve months were negative (-53.93).